HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM [Phase 4]
Phase 4 clinical trial update examining persistence of antiretroviral therapy in different body compartments among HIV-negative men who have…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection [Phase 3]
Phase 3 pharmacokinetic and safety study in pregnant women with HIV completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Neurocognitive Effects of Opiate Agonist Treatment [Phase 4]
Phase 4 clinical trial update examining neurocognitive effects of opiate agonist treatment in opioid-related disorders with HIV co-occurrenc…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Zinc Supplementation and Cardiovascular Risk in HIV [NA]
A completed clinical trial investigating zinc supplementation and cardiovascular risk in HIV patients; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals [Phase 1]
Phase 1 trial evaluating combination therapy with 3BNC117 and 10-1074 in HIV-infected individuals was terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women [Phase 2]
Phase 2 trial evaluating VRC01 antibody for reducing acquisition of HIV-1 infection in women has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men [Phase 2]
Phase 2 trial evaluating VRC01 antibody to reduce acquisition of HIV-1 infection among men and transgender women who have sex with men; stud…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. [Phase 2]
A Phase 2 open-label randomized trial evaluating valganciclovir for reducing mortality in severe IRIS-Kaposi sarcoma; completed with results…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Second-line Switch to Dolutegravir Study [Phase 4]
A Phase 4 clinical trial examining switching to dolutegravir as a second-line therapy for HIV-1 infection has been completed.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy [Phase 2, Phase 3]
Clinical trial evaluating switching to VM-1500A-LAI + 2 NRTIs from first-line ART for HIV-1 infection (Phase 2/3).
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users [Phase 2]
Phase 2 trial evaluating a smartphone intervention to improve HAART adherence among people with HIV and drug use disorders has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
A prospective longitudinal study investigating endothelial function in HIV/HCV coinfected individuals; trial completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
A completed prospective cohort study evaluating HIV and Zika outcomes in infants and pregnancy with posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA® [Phase 1, Phase 2]
Open-label, randomized study assessing efficacy, safety and dose selection of VM-1500A-LAI in HIV-1-infected patients transitioning from NNR…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Early ART to Limit Infection and Establishment of Reservoir [Phase 2]
Phase 2 trial update reporting results from starting antiretroviral therapy early to limit HIV infection and prevent establishment of viral …
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South [NA]
A completed clinical trial (MySTYLE) evaluating online family-based HIV prevention for non-heterosexual Black adolescent males in the South;…
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy [Phase 4]
Phase 4 trial evaluating low-dose colchicine for efficacy and safety on surrogate cardiovascular markers in people living with HIV on antire…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants [Phase 3]
Phase 3 trial update noting continued access to etravirine for treatment-experienced HIV-1 infected participants, with results posted in Dec…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age [Phase 4]
Clinical trial update for switching to B/F/TAF in treatment-experienced people with HIV aged 65 and older (Phase 4).
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: The Treatment Ambassador Program: A Pilot Intervention to Increase Treatment Initiation [NA]
A completed clinical trial evaluating a Treatment Ambassador Program as a pilot intervention to increase initiation of HIV treatment.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients [Phase 4]
Phase 4 trial evaluating a smartphone intervention to aid smoking cessation and improve adherence to treatment among people with HIV; study …
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons [Phase 1]
Phase 1 trial evaluating the safety and activity of a combination therapy (VRC07-523LS and Vorinostat) in HIV-1 infected individuals has com…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV [Phase 2]
Phase 2 clinical trial evaluating pharmacokinetics, safety, and efficacy of dolutegravir dispersible tablets in young children living with H…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection [NA]
A completed clinical trial evaluating the safety and efficacy of a fixed-dose combination of dolutegravir/abacavir/lamivudine initiated duri…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Oligonucleotide Ligation Assay (OLA) Resistance Study [NA]
This clinical trial update describes an Oligonucleotide Ligation Assay (OLA) resistance study in HIV-positive participants. The study has co…